Cargando…
Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
INTRODUCTION: Currently there are no biomarkers that are predictive of when patients with type-2 diabetes (T2D) will progress to more serious kidney disease i.e., diabetic nephropathy (DN). Biomarkers that could identify patients at risk of progression would allow earlier, more aggressive treatment...
Autores principales: | Harkin, Carla, Cobice, Diego, Brockbank, Simon, Bolton, Stephanie, Johnston, Frances, Strzelecka, Anna, Watt, Joanne, Kurth, Mary Jo, Lamont, John V., Fitzgerald, Peter, Moore, Tara, Ruddock, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276980/ https://www.ncbi.nlm.nih.gov/pubmed/35846341 http://dx.doi.org/10.3389/fendo.2022.887237 |
Ejemplares similares
-
Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy
por: Harkin, Carla, et al.
Publicado: (2023) -
Spatial localization of β-unsaturated aldehyde markers in murine diabetic kidney tissue by mass spectrometry imaging
por: Harkin, Carla, et al.
Publicado: (2022) -
Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score
por: McBride, William T., et al.
Publicado: (2019) -
Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
por: Watt, Joanne, et al.
Publicado: (2022) -
Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018)